A clinical trial has begun which will use stem cell transplants to grow a new immune system for people with untreatable Crohn’s disease – a painful and chronic intestinal disease which affects at least 115,000 people in the UK.
The study, led by Queen Mary University of London and Barts Health NHS Trust, is funded with £2m from a Medical Research Council and National Institute for Health Research partnership, and will be recruiting patients from centres in Cambridge, Edinburgh, Liverpool, London, Nottingham, Oxford and Sheffield. The trial is coordinated through the Clinical Trials Unit at the University of Sheffield.
Crohn’s disease is a long-term condition that causes inflammation of the lining of the digestive system, and results in diarrhoea, abdominal pain, extreme tiredness and other symptoms that significantly affect quality of life.
Current treatments include drugs to reduce inflammation but these have varying results, and surgery is often needed to remove the affected part of the bowel. In extreme cases, after multiple operations over the years, patients may require a final operation to divert the bowel from the anus to an opening in the stomach, called a stoma, where stools are collected in a pouch.
‘We might be able to radically alter the course of the disease’
Chief investigator Professor James Lindsay from Queen Mary’s Blizard Institute and a consultant at Barts Health NHS Trust said: “Despite the introduction of new drugs, there are still many patients who don’t respond, or gradually lose response, to all available treatments. Although surgery with the formation of a stoma may be an option that allows patients to return to normal daily activities, it is not suitable in some and others may not want to consider this approach.
“We’re hoping that by completely resetting the patient’s immune system through a stem cell transplant, we might be able to radically alter the course of the disease. While it may not be a cure, it may allow some patients to finally respond to drugs which previously did not work.”
Helen Bartlett, a Crohn’s disease patient who had stem cell therapy at John Radcliffe Hospital, Oxford, said: “Living with Crohn’s is a daily struggle. You go to the toilet so often, you bleed a lot and it’s incredibly tiring. You also always need to be careful about where you go. I’ve had to get off trains before because there’s been no toilet, and I needed to go there and then.
“I’ve been in and out of hospital for the last twenty years, operation after operation, drug after drug, to try to beat this disease. It’s frustrating, it’s depressing and you just feel so low.
“When offered the stem cell transplant, it was a complete no brainer as I didn’t want to go through yet more failed operations. I cannot describe how much better I feel since the treatment. I still have problems and I’m always going to have problems, but I’m not in that constant pain.”
Giving patients a new immune system
The Latest on: Crohn’s disease
via Google News
The Latest on: Crohn’s disease
- Living on an IV bag, Minneapolis runner won't let Crohn's disease slow her down on October 5, 2018 at 4:04 pm
If you think long-distance running is tough, try doing it hooked up to an intravenous bag. Sonya Goins has been training for months to run the Medtronic TC 10 Mile race Sunday, a popular prelude to th... […]
- Allergan Launches Personalized Study Approach for Clinical Research Programs in Inflammatory Bowel Disease on October 5, 2018 at 4:30 am
DUBLIN, Oct. 5, 2018 /PRNewswire/ -- Allergan plc AGN, +0.29% today announced the initiation of two global clinical research programs for brazikumab, an investigational drug being studied for inflamma... […]
- Study reveals factors linked to the development of Crohn's disease on October 4, 2018 at 11:31 pm
How cells talk to each other, and what they say, has long held fascination for Seema Khurana, professor of biology and biochemistry. Recently Gastroenterology Journal published her findings about how ... […]
- Medical News Today: Are probiotics good or bad for Crohn's disease? on October 4, 2018 at 10:00 am
Researchers are increasingly looking into whether probiotics can help reduce symptoms for people with inflammatory bowel diseases, including Crohn's disease. In this article, we look at the ... […]
- Marker may help target treatments for Crohn’s patients on October 4, 2018 at 6:51 am
Crohn’s disease (CD), a chronic inflammatory condition of the intestinal tract, has emerged as a global disease, with rates steadily increasing over the last 50 years. Experts have long suspected that ... […]
- Genomic study finds a new role for microRNAs as predictors of Crohn's disease progression on October 4, 2018 at 6:03 am
Crohn's disease is a lifelong condition characterized by a fluctuating course of gastro-intestinal inflammation with repeated flares and remissions. Any part of the alimentary tract from the mouth ... […]
- Crohn’s Disease Market Expected to Grow Consistently with a Healthy CAGR Says Pfizer Inc., Johnson & Johnson Services Inc. by 2022 on October 4, 2018 at 4:47 am
Crohn’s Disease is a type of Inflammatory Bowel Disease (IBD) that affects any part of the gastrointestinal tract from mouth to anus. Increasing demand for biologics for treating or preventing bowel d... […]
- Comedian Tom Papa to bring laughs, but effort behind Crohn's & Colitis fundraiser is serious on October 3, 2018 at 12:53 pm
The Crohn’s & Colitis Foundation is a nonprofit, volunteer-driven organization whose mission is to cure Crohn’s disease and ulcerative colitis and improve the quality of life for those affected by the ... […]
- Givin’ It All For Guts recognizes disease management on October 3, 2018 at 8:00 am
ALTON — Crohn’s disease need not be a lifetime managment battle — just ask top Realtor Casey Bennington, 32, this year’s honoree at Madison County, Illinois-based Givin’ It All For Guts’ annual event. ... […]
via Bing News